← Back to Search

Light Therapy

Light Therapy for Delayed Sleep Phase Syndrome

Phase 4
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary sleep complaint consistent with delayed sleep phase disorder
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly for four weeks
Awards & highlights

Study Summary

This trial tests if flashes of light can help teens with DSPD wake up in the morning, go to bed early, and reduce fatigue & depression.

Who is the study for?
This trial is for high school students who have trouble waking up early and falling asleep at night, often feeling depressed or restless during the day. It's specifically designed to help those with Delayed Sleep Phase Disorder (DSPD).Check my eligibility
What is being tested?
The study is testing if brief light flashes during sleep can help treat DSPD. The goal is to see if this method can adjust the participants' sleep patterns to a more conventional timing.See study design
What are the potential side effects?
Since the intervention involves light flashes, potential side effects may include temporary discomfort due to being woken up or disturbed during sleep by the flashes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have trouble falling asleep at a conventional time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the begining and end of intervention (4 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the begining and end of intervention (4 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sleep quality
Secondary outcome measures
Mood

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: LightExperimental Treatment1 Intervention
one hour of a sequence of light flashes (4000 lux, 3 msec, every 30 seconds); occurs during hour immediately prior to desired waketime
Group II: Fake lightPlacebo Group1 Intervention
during hour immediately prior to desired waketime, subjects will receive one light flash (insufficient to cause phase shift)

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,330 Total Patients Enrolled
3 Trials studying Delayed Sleep Phase Syndrome
360 Patients Enrolled for Delayed Sleep Phase Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,777 Total Patients Enrolled
VA Palo Alto Health Care SystemFED
87 Previous Clinical Trials
56,843 Total Patients Enrolled

Media Library

Light Flashes (Light Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT01406691 — Phase 4
Delayed Sleep Phase Syndrome Research Study Groups: Light, Fake light
Delayed Sleep Phase Syndrome Clinical Trial 2023: Light Flashes Highlights & Side Effects. Trial Name: NCT01406691 — Phase 4
Light Flashes (Light Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01406691 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What adverse effects have been associated with exposure to Light?

"The Power team has rated Light as a 3 on the safety scale due to this being an approved Phase 4 trial."

Answered by AI

Are geriatric participants being included in this experiment?

"The parameters for participation in this trial stipulate that the age range of acceptable applicants is 15 to 19 years old. There are currently 251 trials open to those under 18, and 642 available for people over 65."

Answered by AI

Are new participants currently being sought for this research endeavor?

"Clinical trials registry reveals that this clinical trial is actively enrolling participants and has been ammended as recently as March 22, 2023. The study was first made available on December 1st 2013."

Answered by AI

What is the total capacity of participants in this trial?

"Correct. Per the information hosted on clinicaltrials.gov, this medical trial is actively searching for participants since its initial posting on December 1st 2013 and most recently updated on March 22nd 2023. The study requires enrolment of twenty patients from a single healthcare facility."

Answered by AI

To whom is enrollment in this trial accessible?

"To be eligible for this study, applicants must suffer from delayed sleep phase syndrome and fall within the 15 to 19 age bracket. Currently, a total of 20 individuals are being sought after."

Answered by AI
~6 spots leftby Jun 2028